Limits...
Social, economic, and health utility considerations in the treatment of overactive bladder.

Sacco E, Tienforti D, D'Addessi A, Pinto F, Racioppi M, Totaro A, D'Agostino D, Marangi F, Bassi P - Open Access J Urol (2010)

Bottom Line: Health utilities are instruments that allow a measurement of QoL and its integration in the economic evaluation using the quality-adjusted life-years model and cost-utility analysis.The development of suitable instruments for quantifying utility in the specific group of OAB patients is vitally important to extend the application of cost-utility analysis in OAB and to guide healthcare resources allocation for this disorder.Studies are required to define the cost-effectiveness of available pharmacological and nonpharmacological therapy options for this disorder.

View Article: PubMed Central - PubMed

Affiliation: Urologic Clinic, Department of Surgery, "Agostino Gemelli" Hospital, Catholic University Medical School, Rome, Italy.

ABSTRACT
Overactive bladder (OAB) is a highly prevalent urinary syndrome with a profound impact on quality of life (QoL) of affected patients and their family because of its adverse effects on social, sexual, interpersonal, and professional function. Cost-of-illness analyses showed the huge economic burden related to OAB for patients, public healthcare systems, and society, secondary to both direct and indirect costs; however, intangible costs related to QoL impact are usually omitted from these analyses. Recently many novel treatment modalities have been introduced and the need to apply the modern methodology of health technology assessment to these treatment strategies was immediately clear in order to evaluate objectively their value in term of both improvement in length/quality of life and costs. Health utilities are instruments that allow a measurement of QoL and its integration in the economic evaluation using the quality-adjusted life-years model and cost-utility analysis. The development of suitable instruments for quantifying utility in the specific group of OAB patients is vitally important to extend the application of cost-utility analysis in OAB and to guide healthcare resources allocation for this disorder. Studies are required to define the cost-effectiveness of available pharmacological and nonpharmacological therapy options for this disorder.

No MeSH data available.


Related in: MedlinePlus

Heath-related utility scores based on the mean EQ5Dindex, in a patients population with OAB symptoms and continence/incontinence/stress incontinence. Reproduced with permission from Currie CJ, Mcewan P, Poole CD, Odeyemi IA, Datta SN, Morgan CL. The impact of the overactive bladder on health-related utility and quality of life. BJU Int. 2006;97:1267–1272.41 Copyright © 2006 Wiley-Blackwell.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3818873&req=5

f4-oaju-2-011: Heath-related utility scores based on the mean EQ5Dindex, in a patients population with OAB symptoms and continence/incontinence/stress incontinence. Reproduced with permission from Currie CJ, Mcewan P, Poole CD, Odeyemi IA, Datta SN, Morgan CL. The impact of the overactive bladder on health-related utility and quality of life. BJU Int. 2006;97:1267–1272.41 Copyright © 2006 Wiley-Blackwell.


Social, economic, and health utility considerations in the treatment of overactive bladder.

Sacco E, Tienforti D, D'Addessi A, Pinto F, Racioppi M, Totaro A, D'Agostino D, Marangi F, Bassi P - Open Access J Urol (2010)

Heath-related utility scores based on the mean EQ5Dindex, in a patients population with OAB symptoms and continence/incontinence/stress incontinence. Reproduced with permission from Currie CJ, Mcewan P, Poole CD, Odeyemi IA, Datta SN, Morgan CL. The impact of the overactive bladder on health-related utility and quality of life. BJU Int. 2006;97:1267–1272.41 Copyright © 2006 Wiley-Blackwell.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3818873&req=5

f4-oaju-2-011: Heath-related utility scores based on the mean EQ5Dindex, in a patients population with OAB symptoms and continence/incontinence/stress incontinence. Reproduced with permission from Currie CJ, Mcewan P, Poole CD, Odeyemi IA, Datta SN, Morgan CL. The impact of the overactive bladder on health-related utility and quality of life. BJU Int. 2006;97:1267–1272.41 Copyright © 2006 Wiley-Blackwell.
Bottom Line: Health utilities are instruments that allow a measurement of QoL and its integration in the economic evaluation using the quality-adjusted life-years model and cost-utility analysis.The development of suitable instruments for quantifying utility in the specific group of OAB patients is vitally important to extend the application of cost-utility analysis in OAB and to guide healthcare resources allocation for this disorder.Studies are required to define the cost-effectiveness of available pharmacological and nonpharmacological therapy options for this disorder.

View Article: PubMed Central - PubMed

Affiliation: Urologic Clinic, Department of Surgery, "Agostino Gemelli" Hospital, Catholic University Medical School, Rome, Italy.

ABSTRACT
Overactive bladder (OAB) is a highly prevalent urinary syndrome with a profound impact on quality of life (QoL) of affected patients and their family because of its adverse effects on social, sexual, interpersonal, and professional function. Cost-of-illness analyses showed the huge economic burden related to OAB for patients, public healthcare systems, and society, secondary to both direct and indirect costs; however, intangible costs related to QoL impact are usually omitted from these analyses. Recently many novel treatment modalities have been introduced and the need to apply the modern methodology of health technology assessment to these treatment strategies was immediately clear in order to evaluate objectively their value in term of both improvement in length/quality of life and costs. Health utilities are instruments that allow a measurement of QoL and its integration in the economic evaluation using the quality-adjusted life-years model and cost-utility analysis. The development of suitable instruments for quantifying utility in the specific group of OAB patients is vitally important to extend the application of cost-utility analysis in OAB and to guide healthcare resources allocation for this disorder. Studies are required to define the cost-effectiveness of available pharmacological and nonpharmacological therapy options for this disorder.

No MeSH data available.


Related in: MedlinePlus